Harvest Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Harvest Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80,000	Closed	-$3.18M	–	74
2026 Q1	$3.18M	Buy	+80,000	New	+$2.05M	1.54%	15

Harvest Management's CNTA Position: Q2 2026 in Review

Harvest Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 80,000 shares — an estimated $3.18M sold.

Harvest Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $3.18M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Harvest Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Harvest Management sold 80,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $3.18M.
Harvest Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Harvest Management's Centessa Pharmaceuticals position peaked at $3.18M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.